Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a newer release of the page content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded the Squamous cell carcinoma of the head and neck term and a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.4.2 is now displayed. The earlier government funding/operating-status notice has been removed.SummaryDifference0.4%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.